Anterior Cutaneus Nerve Block With USG for Total Knee Replacement

Nerve Block Clinical Trial

Official title:

Contribution of Anterior Femoral Cutaneous Nerve Block to Postoperative Analgesia for Total Knee Replacement

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT06201195
• Other study ID #: AESH-EK1-2023-556
• Status: Recruiting
• Phase: N/A
• Start date: October 1, 2023
• Est. completion date: February 25, 2024

Study information

• Verified date: December 2023
• Source: Diskapi Teaching and Research Hospital
• Contact: Derya Ozkan, professor MD
• Phone: 0903127970000
• Email: derya_z[@]yahoo.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The goal of this clinical trial is to compare analhesia effects of adductor canal blockade versus distal adductur canal blockade added anterior cutaneus nerve block in total knee arthroplasty. The main questions it aims to answer are: - question 1: does distal adductor canal blockade + anterior cutaneus nerve blokade superior analgesia then adductor canal block for undergoing TKP? - question 2: does distal adductor canal blockade + anterior cutaneus nerve blokade decrease drain place pain on anterolateral face of knee?

Description:

Patients with American Society of Anesthesiologists classification status I-III scheduled for elective primary TKA using standard spinal anesthesia enroll for this trial. After surgery patient divided two groups: 1- adductor canal blockade 2- distal adductor canal blockade + anterior femoral cutaneus nerve blockade. At postoperative 3th, 10th, 24th hour VAS (visuel analouge scale), VAS move, incision plase pain-for top and down of patella, drain place pain, motor strenght for femoral nerve and siyatic nerve, first analjesic requirement time, opioid consumption, total analcesic requirement will be recorded.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 60
• Est. completion date: February 25, 2024
• Est. primary completion date: January 20, 2024
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 40 Years to 75 Years

Eligibility

Inclusion Criteria:

• Total knee artroplasty
• Spinal anesthesia
• ASA 1-3

Exclusion Criteria:

• Bupivacaine allergy
• Coagulopathy
• Infection on injection site

Related Conditions & MeSH terms

• Knee Replacement Arthroplasty
• Nerve Block
• Pain Measurement

Intervention

Procedure:
• Adductor canal blockade
VAS, VAS move, incision place pain for up and down to patella, drain place pain, motor strenght for femoral nerve and siyatic nerve muscles, side effects, first analgesic requirement time, opioid requirement, other analgesics
• Distal adductor canala blockade and anterior cutaneus nerve blockade
VAS, VAS move, incision place pain for up and down to patella, drain place pain, motor strenght for femoral nerve and siyatic nerve muscles, side effects, first analgesic requirement time, opioid requirement, other analgesics

Locations

Country	Name	City	State
Turkey	Ankara Etlik City Hospital	Ankara

Sponsors (1)

Lead Sponsor	Collaborator
Diskapi Teaching and Research Hospital

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	VAS (visuel analouge scale)	for postoperative pain evaluation after TKA surgery. The visual analogue scale (VAS) uses a 10 cm line with endpoint descriptors such as 'no pain' marked at the left end of the line and 'worst pain imaginable' marked at the right end.	postblock 3 hour,10 hour, 24 hour
Primary	drain place pain	do you have any pain on drain place? yes or no	postblock 3 hour,10 hour, 24 hour
Secondary	VAS movement	Postoperative pain with knee moves evaluate with VAS, The visual analogue scale (VAS) uses a 10 cm line with endpoint descriptors such as 'no pain' marked at the left end of the line and 'worst pain imaginable' marked at the right end.	postblock 3 hour,10 hour, 24 hour
Secondary	motor strenght	leg elevation and plantar flexion	postblock 3 hour,10 hour, 24 hour